New Delhi: A central team, which visited Patna and Gaya earlier this week has shared its inputs about the spiralling coronavirus disease (Covid-19) cases with the state and has warned low testing ratio may impact its case fatality rate of the viral outbreak in Bihar.
After the state started registering spike in COVID-19 cases, the three-member team lead by Lav Agarwal, joint secretary, Union Ministry of Health & Family Welfare (MoH&FW) had recently visited Bihar to take stock of the situation.
"The very low testing ratio as compared to the national average might impact the state's case fatality rate," the team said in its report said.
Bihar has registered testing ratio at 3423 per million population, while the mortality rate stands at 0.69 %.
Expressing concern over the spike in the Covid-19 positivity rate, the central team cautioned the Nitish Kumar-led government that low testing could lead to a spread in the infection and asked the administration to conduct rapid antigen detection test in containment areas of the state.
Bihar till date registered 30,369 COVID positive cases out of which 10,506 cases are still active. As many as 217 people have died due to Covid-19.
Meanwhile, India during the last 24 hours recorded the highest ever single-day recovery of nearly 30,000 patients taking the total number of recovery cases to 782606 patients with 63.18 per cent. The gap between recovered and active cases now stands at 356439 cases. There are 4,26,167 active cases present across India.
Meanwhile, Dr Dangs Lab, a Delhi-based private laboratory on Wednesday claimed that it has been selected as the central lab for human clinical trials of COVAXIN.
In a statement, Dr Dangs Lab has said, "We are extremely privileged to announce that Dr Dangs Lab, New Delhi has been provided the opportunity to serve the nation by being selected as the central lab for the human clinical trials of COVAXIN."
Also read: Bihar's health infrastructure crumbles as cases mount
